Key Highlights
- Amesite (AMST) stock skyrocketed 190% during Tuesday’s premarket session following the announcement of its biggest enterprise contract.
- The new client will implement NurseMagic AI documentation solutions for a care team managing roughly 2,700 patients.
- NurseMagic will be integrated with the client’s electronic medical records (EMR) and electronic visit verification (EVV) platforms.
- The system aims to reduce documentation workload for caregivers by as much as 16 hours weekly per employee.
- The company has successfully decreased operational expenditures by approximately 18% across the past six quarters.
On May 18, 2026, Amesite Inc. revealed it had won a major home care enterprise account for its NurseMagic AI documentation solution — marking the company’s most substantial client acquisition ever. The announcement triggered a dramatic 190% spike in AMST stock during premarket hours Tuesday.
The newly acquired enterprise client oversees care for approximately 2,700 patients and plans to implement NurseMagic throughout its entire caregiver workforce. The AI-powered platform will be fully integrated with both the organization’s electronic medical record infrastructure and electronic visit verification technology.
The deployment’s primary objective centers on dramatic time efficiency gains. Currently, healthcare documentation responsibilities consume up to 16 hours weekly for each caregiver, and NurseMagic is engineered to significantly reduce this administrative load.
Company Founder and CEO Dr. Ann Marie Sastry emphasized the significance: “This deployment serving 2,700 patients validates our architectural approach.” She highlighted that Amesite can rapidly onboard new clients without the expensive consulting fees and custom development expenses associated with traditional legacy solutions.
The implementation accommodates diverse user roles, sophisticated permission hierarchies, and customized documentation workflows across thousands of patient records — all without the extended setup periods that can stretch for weeks or even months with conventional systems.
Financial Performance Reflects Controlled Growth Strategy
This major contract arrives as Amesite has actively streamlined its operational expenses. Sarah Berman, Principal Finance and Accounting Officer, highlighted roughly an 18% decline in operating costs throughout the previous six quarters, even while the company expanded its base of paying customers.
This combination of fiscal discipline and business expansion carries particular weight for a micro-cap equity. Amesite maintains a market capitalization of approximately $4.48 million, making any significant enterprise contract financially material.
Madison Bush, Director of Corporate Operations, shared that the company’s sales and marketing initiatives are driving about 4,200 daily website visits. She further revealed that more than 70% of qualified prospects currently in discussions have independently scheduled product demonstrations through the company’s website.
Strong Pipeline Suggests Additional Opportunities
Beyond this current implementation, Amesite disclosed ongoing conversations with other organizations collectively representing thousands of additional patients. The company has not publicly identified these potential clients or provided specific timelines for potential deals.
NurseMagic currently operates across more than 100 healthcare professions throughout all 50 states and in 21 countries worldwide. The platform includes multilingual functionality and maintains full compliance with HIPAA regulatory standards.
The stock maintains an average daily trading volume near 682,000 shares. Technical indicators for the equity currently suggest a sell rating, though this assessment predates Tuesday’s major announcement.
The 2,700-patient contract represents the company’s most substantial deal to date and, according to executive leadership, signals NurseMagic’s evolution from a supplementary assistance tool into what management characterizes as essential clinical infrastructure within the non-acute healthcare sector.
